Clinical Trial Update: Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial investigating dopamine receptor contributions to prediction error and reversal learning in anorexia nervosa. The study has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa

Snippet

Sponsor: University of California, San Diego | Conditions: Anorexia Nervosa | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-04-11